ARTICLE | Company News
Kymab, Regeneron antibodies news
October 13, 2014 7:00 AM UTC
Kymab said the European Patent Office (EPO) has granted Kymab's request to entirely revoke Regeneron's EP1,360,287B1 patent related to genetically modified mice containing mouse antibody variable regi...